Imagine a smart, invisible shield that you can spray or dip a medical tool into to stop germs from growing. It works like a protective skin that keeps bacteria, fungi, and viruses away from implants or open wounds. This helps the body heal faster and prevents the dangerous infections that often happen after surgery.
Medical device-related infections cause millions of extra hospital days and billions in costs, often leading to implant rejection in 5% of patients.
A handheld device (protect|ION) for applying antimicrobial membranes and an industrial dipping robot for large-scale coating application.
If you are an implant manufacturer dealing with a 5% patient rejection rate due to infections — this project developed a multifunctional coating that prevents bacteria and inflammation. This can be applied via a customized coating service to reduce failure rates.
If you are a hospital dealing with infection rates between 10-15% in surgical wounds — this project developed protect|ION, a handheld device that applies thin membranes to wounds. This reduces infection risks and can save hundreds of millions in healthcare costs.
If you are a cosmetics company dealing with the need for antimicrobial and antiviral hygiene products — this project developed a biocompatible, eco-friendly spray and hair-specific formulations. These products are proven effective against fungi like Aspergillus spp.
Based on available project data, the technology aims to reduce healthcare costs by addressing infections that currently cost over €7B annually and cause 16M additional hospitalization days.
Yes, the project has successfully developed and operationalized a prototype of an industrial dipping robot and established a full production chain.
The company has filed 2 patents, submitted the trademark ION|aspis, and offers a customized coating development service that leads to recurring licensing.
The protect|ION device has been classified as a Class IIB medical device under EU MDR 2017/745, and the QMS is aligned with ISO 13485/14971.
The project has manufactured a production-friendly version for clinical trials and has already engaged CROs and hospital partners to prepare protocols.
The project is led by a single French SME, SPARTHA Medical, which is a spin-off from the INSERM Biomaterials Unit. With a 100% industry ratio and a lean single-partner structure, the project is highly focused on commercialization and rapid deployment rather than academic research, as evidenced by the focus on MDR classification and industrial robotics.
Contact SPARTHA Medical in France regarding licensing for antimicrobial coatings.
Contact us to explore licensing opportunities for the ION|aspis coating platform.
